机器人全肝移植45例经验与结局
这项回顾性多中心队列研究纳入2个欧洲中心2024年2月至2025年10月连续接受机器人全肝移植的患者,最终44例纳入分析,主要终点为与肝移植基准标准的比较。结果显示除手术时间外所有基准阈值均达到,总体死亡率为2.3%,转开腹率9.1%。
要点
- 机器人全肝移植除手术时间外达到肝移植基准结局标准
- 总体死亡率2.3%,转开腹率9.1%且均顺利恢复
- 中位手术时间551分钟,随学习曲线显著改善
核心结论
- 机器人全肝移植在主要围术期和早期移植后参数上达到基准水平结局。
- 尽管手术时间因操作复杂性和学习曲线而延长,在具有先进移植和机器人肝胆专业知识的高度专业化中心实施时安全且可重复。
研究设计与样本
- 回顾性多中心队列研究,纳入2个欧洲中心2024年2月至2025年10月连续接受机器人全肝移植的患者。
- 45例符合纳入标准,1例因机器人对接前中转被排除,最终队列44例。
主要发现
- 肝细胞癌是主要移植适应证(47.7%)。
- 中位MELD评分11(范围6-28),61.4%受者存在临床显著门脉高压。
- 中位手术时间551分钟,中位热缺血时间60分钟。
- 中转开腹4例(9.1%),均顺利恢复。
- 中位ICU和住院时间分别为2天和10天,总体死亡率2.3%。
关键数值与推荐
- 除手术时间外所有基准阈值均达到,手术时间随时间显著改善。
临床怎么用
- 机器人全肝移植可在具有先进移植和机器人肝胆专业知识的高度专业化中心开展,围术期结局可达基准水平。
- 手术时间延长与操作复杂性和学习曲线相关,需在中心建设中予以考虑。
局限性
- 回顾性研究设计。
- 仅纳入2个欧洲中心,样本量44例。
- 原文未报告长期随访结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Robotic liver transplantation (RLT) represents the latest evolution in solid organ transplantation. While early reports demonstrated technical feasibility of whole-graft RLT, evidence on clinical outcomes benchmarked against established standards remains limited. This study aimed to evaluate perioperative post-transplant outcomes of whole-graft RLT and to assess whether benchmark performance can be achieved in clinical practice. STUDY DESIGN: This retrospective multicenter cohort study included consecutive patients undergoing whole-graft RLT at 2 European centers between February 2024 and October 2025. Preoperative, perioperative, and follow-up data were retrieved from prospectively maintained databases. The primary endpoint was comparison of outcomes with LT benchmark criteria. RESULTS: Forty-five patients met inclusion criteria; one was excluded due to conversion before robotic docking, yielding a final cohort of 44 patients. Hepatocellular carcinoma was the leading indication for transplantation (47.7%). Median MELD score was 11 (range 6-28), and 61.4% of recipients had clinically significant portal hypertension. Median operative time was 551 minutes, with a median warm ischemia time of 60 minutes. Conversion to open surgery occurred in 4 cases (9.1%), all of which recovered uneventfully. Median ICU and hospital stay were 2 and 10 days, respectively. Overall mortality was 2.3%. All benchmark thresholds were met except operative time, which significantly improved over time. CONCLUSION: Robotic whole-graft liver transplantation achieved benchmark-level outcomes for major perioperative and early post-transplant parameters. Despite prolonged operative duration related to procedural complexity and learning curve, RLT appears safe and reproducible when implemented in highly specialized centers with advanced transplant and robotic hepatobiliary expertise.
引用
- Di Benedetto F, Magistri P, Coelho JS, et al. Robotic Whole-graft Liver Transplant: Lesson Learned And Outcomes After 45 Cases. Ann Surg. 2026. PMID: 42557614. doi:10.1097/SLA.0000000000007181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。